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Introduction 
 
Knee osteoarthritis (OA) is a degenerative joint disease characterized by erosion of cartilage coupled 
with inflammation of the joint, eventually leading to pain and loss of function. If conservative treatment fails, 
total joint replacement may be the only option left open. This indicates that new insights into possibilities for 
delaying OA progression are necessary. Macrophages, together with fibroblasts, are present in the synovial 
lining of joints. They are involved in synovial inflammation, and have been shown to play a prominent role in 
the progression of OA [1]. Macrophages can become activated and may acquire a phenotype, ranging from 
pro-inflammatory (M1) to anti-inflammatory (M2) [2]. In vitro, pro-inflammatory macrophages develop when 
monocytes are subjected to interferon-γ (IFN-γ) and lipopolysaccharide (LPS) or tumor necrosis factor alpha 
(TNFα) [3]. They have high microbicidal activity and secrete large amounts of pro-inflammatory cytokines. 
Anti-inflammatory macrophages can be further divided into subtypes. One of these subtypes, develops when 
monocytes are exposed to IL-4 or IL-13, sometimes referred to as M2a, and these cells are considered 
anti-inflammatory due to their ability to down regulate pro-inflammatory stimuli [4]. Another subtype develops 
when monocytes are stimulated with IL-10, sometimes referred to as M2c, and downregulates pro-inflammatory 
cytokines and plays a role in tissue remodeling [5]. In earlier studies, it has been shown in vitro that 
bone-marrow derived macrophages [6] and peritoneal macrophages [7] secrete enzymes that may be responsible 
for cartilage degeneration. However, the direct effect of different macrophage phenotypes on cartilage is not 
clear. We hypothesized that pro-inflammatory macrophages exacerbate the progression of cartilage degeneration 
and anti-inflammatory macrophages can inhibit the progression of cartilage degeneration. Therefore, the direct 
effect of macrophage phenotypes on cartilage was assessed by culturing human articular cartilage with 
phenotype specific macrophage conditioned medium (MCM). 
 
Methods 
 
Preparation of subtype specific MCM 
 
Monocytes were isolated from a total of six buffy coats (males, 61±11 years; Sanquin blood bank, 
Amsterdam, the Netherlands) using Ficoll (GE Healthcare, Little Chalfont, UK) density gradient separation and 
CD14 magnetic-activated cell sorting microbeads (MACS; Miltenyi, Bergisch Gladbach, Germany) as 
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previously described [8]. To prepare MCM, monocytes of three buffy coats were pooled, seeded in culture 
flasks at 500,000 monocytes/cm2 and cultured in X-VIVO-15 (Lonza, Verviers, Belgium) containing 20% heat-
inactivated fetal calf serum (FCS; Lonza), 50 µg/mL gentamicin (Gibco) and 1.5 µg/mL amphotericin B (Gibco) 
at 37°C and 5% CO2. Monocytes were stimulated with 10 ng/mL Interferon-γ (IFNγ; PeproTech, Rocky Hill, 
NJ, USA) and 10 ng/mL Tumor Necrosis Factor-α (TNFα, PeproTech) to obtain pro-inflammatory 
M(IFNγ+TNFα) macrophages. The anti-inflammatory M(IL-4) subtype was obtained after stimulation with 10 
ng/mL Interleukin-4 (IL-4; PeproTech). M(IL-10) was acquired by stimulation with 10 ng/mL IL-10 
(PeproTech). After 48h, the medium used to differentiate the macrophages containing serum and stimuli was 
removed and the macrophages were washed twice with 0.9% NaCl (Sigma-Aldrich) before the addition of 
serum-free Dulbecco’s Modified Eagle Medium, low glucose (DMEM; Gibco) supplemented with 1% 
Insulin-Transferrin-Selenium (ITS+ premix, Biosciences, New Jersey, USA), 50 µg/mL gentamicin, 1.5 µg/mL 
amphotericin B) and 25 µg/mL L-ascorbic acid 2-phosphate (Sigma-Aldrich) to obtain MCM. After 24h, the 
MCM was harvested, centrifuged at 200g and stored at -80°C until use. Non-conditioned DMEM supplemented 
with 1% Insulin-Transferrin-Selenium (ITS+ premix, Biosciences, New Jersey, USA), 50 µg/mL gentamicin, 
1.5 µg/mL amphotericin B) and 25 µg/mL L-ascorbic acid 2-phosphate (Sigma-Aldrich) was also incubated, 
centrifuged and frozen to serve as control medium. Cells were harvested for DNA quantification using a 
modified CyQUANT assay (Invitrogen, Carlsbad, USA) as described previously [9].  
 
Cartilage explant culture in MCM 
 
Human articular cartilage was obtained with implicit consent as waste material from patients 
undergoing total knee replacement surgery for which the patients had the rights to refuse. This protocol was 
approved by the medical ethical committee of the Erasmus Medical Center, protocol number MEC-2004-322. 
Full thickness cartilage explants (ø=5mm) were harvested from macroscopically intact areas of the femoral 
condyles and tibia plateau and washed twice with 0.9% NaCl. Samples were pre-cultured for 24h in DMEM, 
followed by culture with 50% MCM (n=6 cartilage donors, 68±7Y), or a combination of 50% M(IFNγ+TNFα) 
plus 50% M(IL-4) or M(IL-10) MCM (n=3 cartilage donors, 68±6 years). To simulate acute inflammation, 
cartilage explants (n=3 cartilage donors, 61±4 years) were pre-stimulated for 24h with 10 ng/mL IFNγ and 10 
ng/mL TNFα, followed by culture with 50% MCM. The MCM was completed with 50% fresh medium to 
replenish potential nutrient depletion. Explants cultured in DMEM instead of MCM were included as controls. 
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All MCM used for culture and analysis were frozen and thawed once. To account for the cell numbers by which 
the MCM was produced, the average DNA contents of all macrophage phenotypes were defined as 50% and the 
percentage MCM used in culture was adjusted for the DNA content per MCM phenotype as described 
previously [10]. The first MCM batch was used on explants of donor 1-3 and the second batch was used on 
explants of donor 4-10. Donor demographics and culture conditions are presented in Table 1. 
 
Characterization of MCM 
 
To confirm macrophage polarization, IL-6, CCL18 and sCD163 were measured in the second MCM 
batch. In our previous work, we have characterized M(IFNγ+TNFα), M(IL-4) and M(IL-10) primary human 
monocyte-derived macrophages based on gene expression and protein production [3, 8, 10, 11]. IL-6 was found 
to be a good marker for M(IFNγ+TNFα), CCL18 for M(IL-4) and soluble CD163 (sCD163) for M(IL-10) which 
was also supported by others [12, 13].  IL-6 (PeproTech), CCL18 (R&D Systems) and sCD163 (PeproTech) 
protein concentrations were quantified in the MCM using enzyme-linked immunosorbent assays (ELISAs) 
according to manufacturer’s instructions. To check for possible nutrient depletion of the conditioned medium, 
glucose was measured. Glucose concentration was 0.83 g/L for M(IFNγ+TNFα) MCM, 0.93 g/L for M(IL-4) 
MCM, 0.92 g/L for M(IL-10) MCM and 1.0 g/L in non-conditioned medium. Since MCM was mixed 1:1 with 
fresh medium, the difference in glucose between the conditions was maximally 5.5% and considered negligible.   
 
Gene expression analysis of cartilage explants 
 
mRNA isolation and cDNA synthesis of the cartilage explants were executed as described previously 
[9].  qPCR was performed on a Bio-Rad CFX96 Real-Time PCR Detection System (Bio-Rad, Hercules, CA, 
USA) to assess gene expression, matrix metalloproteinase-1 (MMP1; Fw: 
CTCAATTTCAC*TTCTGTTTTCTG; Rev: CATCTCTGTCGGCAAATTCGT; Probe: 
CACAACTGCCAAATGGGCTTGAAGC), MMP13 (Fw: AAGGAGCATGGCGACTTCT; Rev: 
TGGCCCAGGAGGAAAAGC; Probe: CCCTCTGGCCTGCGGCTCA), A disintegrin and metalloproteinase 
with thrombospondin motifs (ADAMTS4; Fw: CAAGGTCCCATGTGCAACGT; Rev: 
CATCTGCCACCACCAGTGTCT; Probe: CATCTGCCACCACCAGTGTCT), ADAMTS5 (Fw: 
TGTCCTGCCAGCGGATGT; Rev: ACGGAATTACTGTACG*GCCTACA; Probe: 
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ACGGAATTACTGTACGGCCTACA), aggrecan (ACAN), Collagen type II (COL2A1) [9], Interleukin-1β 
(IL1B; Fw: CCCTAAACAGATGAAGTGCTCCTT; Rev: GTAGCTGGATGCCGCCAT), IL6, Tumor Necrosis 
Factor-α (TNFA) [8], suppressor of cytokine signaling 1 (SOCS1; Fw: CCCTGGTTGTTGTAGCAGCTT; Rev: 
TTGTGCAAAGATACTGGGTATATGT) and SOCS3 (Fw: TCGGACCAGCGCCACTT; Rev: 
CACTGGATGCGCAGGTTCT) were measured. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [8] 
was found stable and therefore further used as housekeeper gene. The nucleotide marked with an asterisk 
denotes a mismatch in the primer sequence. Gene expression levels of ADAMTS5 and MMP1 in OA cartilage 
were compared with those found in literature [14] and this was similar. Furthermore, since all primer sequences 
were developed using NCBI BLAST according to a protocol to be specific for the gene of interest, we are 
confident that these primer-probe combinations are specific despite a single nucleotide mismatch. Amplification 
efficiency was confirmed using a dilution range of universal human cDNA and the efficiency was calculated 
using the following formula: 10^(-1/slope)-1. The primer was only approved if the slope was between -3.60 and 
-3.20, and if the efficiency was between 0.9 and 1.1. In case the primers were used for a SYBR GR assay, gel 
electrophoresis was conducted on the PCR products to ensure that no primer-dimers were formed and to confirm 
the product size. In case of a Taqman assay, a specific probe was designed to be used in combination with the 
primers to increase specificity. Finally, the following amplification protocol was used: 10 min at 95°C, then 39 
cycles of 95°C for 15s, 60°C for 60s, finishing with a melt curve from 65°C to 95°C with 0.5°C increments of 
5s. The relative expression of the genes of interest was determined by the 2-ΔCT formula. 
 
Nitric oxide (NO) and glycosaminoglycan (GAG) quantification 
 
NO production was measured in the MCM and in the medium of the cartilage explants using Griess 
reagent (Sigma-Aldrich) as an indication of the degree of inflammation. The reaction was monitored at 540 nm 
using a spectrophotometer (VersaMax; Molecular Devices, Sunnyvale, USA). Sodium nitrite (NO2; Chem-lab, 
Zedelgem, Belgium) was used as standard.  
 
GAG release in the MCM and in the medium of the explants was measured with a 1,9-
Dimethylmethylene Blue assay (Sigma-Aldrich) [15] as indication for cartilage degeneration. The reaction was 
monitored using a VersaMax at 530 and 590 nm. Shark chondroitin sulphate C (Sigma-Aldrich) was used as 
standard. 
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Statistics 
 
IBM SPSS 22.0 (IBM, New York, USA) and Microsoft Excel 2010 were used for statistical evaluation. 
Per donor, a minimum of three cartilage samples were used that were randomly divided per experimental 
condition. For PCR analysis, all samples were processed and analyzed individually. These values were used for 
statistical analysis. For the biochemical assays, the mean of a duplicate measurement per sample was used for 
statistical analysis. To take donor variability into account, a mixed linear model after log transformation was 
used. In the model, single or combined phenotype specific MCM (e.g., M(IFNγ+TNFα), M(IL-4) and M(IL-10) 
MCM) and cartilage state (e.g., end-stage OA or pre-stimulated with IFNγ+TNFα) were defined as fixed factors, 
while the cartilage donor was considered as random factor. The tests were adjusted for multiple comparisons by 
a Bonferroni’s post hoc comparisons test. Differences were considered statistically significant for P<0.05. 
 
Results 
 
MCM 
 
To confirm that the MCM was produced by different macrophage subtypes, IL-6, CCL18 and sCD163 
were measured. IL-6 protein concentration was high in M(IFNγ+TNFα) MCM, while undetectable (<62.5 
pg/mL) in M(IL-4) and M(IL-10) MCM. CCL18 protein concentration was highest in M(IL-4) and lower in 
M(IFNγ+TNFα) and M(IL-10). sCD163 was high in M(IL-10) and undetectable (<156 pg/mL) in 
M(IFNγ+TNFα) and M(IL-4) (Figure 1). NO2 concentrations were undetectable (<1.25 µM) in MCM of all 
phenotypes, indicating that no NO was released into the MCM. Since NO was no longer produced by the 
macrophages, this could be used as a parameter to assess the induction of inflammation in cartilage. Average 
GAG concentrations in the MCM were 0.30 µg/mL for all phenotypes. These GAG concentrations were further 
reduced, since 50% MCM was used in the cultures. The final GAG concentrations in the MCM constituted for 
less than 0.04% of the average GAG release of cartilage explants, indicating that GAG production by 
macrophages can be considered negligible.  
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Pro-inflammatory macrophages affect cartilage matrix genes and induce inflammation in osteoarthritic 
cartilage  
 
To assess the direct effect of macrophages with different phenotypes on cartilage, OA cartilage was 
cultured with M(IFNγ+TNFα), M(IL-4) and M(IL-10) MCM and assessed by gene expression analysis, NO 
production and GAG release. Expression of IL1B, IL6, TNFA, SOCS1, MMP13 and ADAMTS5 was higher when 
cartilage was cultured with M(IFNγ+TNFα) MCM than when the cartilage was cultured with non-conditioned 
DMEM, while COL2A1 and ACAN were decreased. M(IL-4) MCM did not significantly affect any of the genes 
of interest, while IL1B and SOCS1 expression was higher in cartilage cultured with M(IL-10) than when 
cultured with DMEM (Figure 2A). NO production by the cartilage was statistically significantly increased when 
cultured with M(IFNγ+TNFα) and M(IL-10) MCM than when cultured with DMEM, while GAG release was 
significantly increased by the explants cultured with M(IFNγ+TNFα) (Figure 2B).  
 
Anti-inflammatory macrophages do not counteract pro-inflammatory processes in OA cartilage 
 
To further investigate possible effects of anti-inflammatory macrophages directly on cartilage, OA 
cartilage was cultured with a combination of M(IFNγ+TNFα) MCM and M(IL-4) MCM or M(IL-10) MCM.  
No inhibiting effects were seen on gene expression levels of the genes of interest when the cartilage was 
cultured with  the combinations of conditioned media of M(IFNγ+TNFα) and M(IL-4) or M(IFNγ+TNFα) and 
M(IL-10) compared to M(IFNγ+TNFα) only (Figure 3A). NO production by the cartilage when cultured with 
M(IFNγ+TNFα) was not counteracted by the addition of  M(IL-4) or M(IL-10) MCM, as NO levels remained 
elevated (Figure 3B). Culture with single phenotype MCM or in combinations did not significantly affect GAG 
release of the cartilage explants (Figure 3C).  
 
M(IL-4) and M(IL-10) do not inhibit acute inflammation or cartilage degeneration in stimulated cartilage 
 
Since we could not detect a clear effect of M(IL-4) and/or M(IL-10) MCM directly on OA cartilage, 
we further investigated the potential effects of the anti-inflammatory macrophages. For this reason, acute 
inflammation was simulated in OA cartilage by 24h pre-stimulation with IFNγ+TNFα. After this 
pre-stimulation, expression of IL6, TNFA, SOCS1, MMP1 and ADAMTS4 was higher in stimulated cartilage 
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than in unstimulated OA cartilage, while COL2A1 was lower (Figure 4A). NO production was higher in 
pre-stimulated cartilage than in unstimulated cartilage and GAG release was not significantly affected (Figure 
4B). These data combined confirm that inflammation was induced, coupled with upregulation of genes that are 
associated with inflammation and matrix degradation, as well as suppression of collagen production. After the 
24h pre-stimulation, the cartilage was cultured for another 48h in the presence of M(IFNγ+TNFα), M(IL-4) or 
M(IL-10) MCM. As expected, culturing the pre-stimulated cartilage with M(IFNγ+TNFα) MCM did not affect 
the genes of interest, indicating that pro-inflammatory macrophages did not further enhance the inflammation 
that was induced during the pre-stimulation period. Unexpectedly, after culturing the pre-stimulated cartilage 
explants with M(IL-4) MCM, only ACAN expression was affected and its expression was lower than when 
cultured in DMEM. Culturing cartilage with M(IL-10) did not affect any of the genes of interest (Figure 5A). 
NO production and GAG release were unaffected by the conditioned medium of either macrophage phenotype 
(Figure 5B). 
 
Discussion 
 
We have shown in this study that pro-inflammatory macrophages exacerbate processes involved in 
degeneration of OA cartilage and induce inflammation, while anti-inflammatory macrophages do not directly 
affect OA cartilage, or inhibit effects of pro-inflammatory macrophages on cartilage. This suggests that 
inhibition of pro-inflammatory macrophages or enhancing the performance of anti-inflammatory macrophages 
may be relevant targets to consider when developing therapies that are aiming at inhibiting cartilage 
degeneration.  
 
Since inflammation plays an important role in the development and progression of OA, development of 
therapies focusing on synovial inflammation is increasing. However, in vitro studies that acknowledge 
macrophage-mediated inflammation in their culture models did not consider the spectrum of phenotypes that 
may be present in in vivo situations [6, 7, 16]. To our knowledge, we are the first to describe the direct effects of 
specific macrophage phenotypes on human articular cartilage. Although the M1/M2-classification of 
macrophages is mainly applicable to in vitro models, by generating subtypes of M2 macrophages, we aimed to 
include a range of macrophages phenotypes that mimic in vivo situations. The macrophage phenotypes were 
confirmed by the protein secretion profiles of IL-6, CCL18 and sCD163. Since these three proteins are also 
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found in the synovial fluid of OA patients [17-21], this suggests that macrophages of various phenotypes may be 
linked to OA pathogenesis and progression.  
 
In this study, M(IFNγ+TNFα) MCM affected OA cartilage by inhibiting genes associated with matrix 
production, upregulation of matrix degenerating genes and induction of inflammation. This was expected and in 
line with previous work, where we have shown that synovial macrophages and monocyte-derived 
pro-inflammatory macrophages negatively affected chondrogenesis of mesenchymal stem cells [10, 22]. In 
contrast, M(IL-4) did not affect OA cartilage, while M(IL-10) seemed to induce inflammation to some extent, 
although less intense than M(IFNγ+TNFα). Both M(IL-4) and M(IL-10) were unable to counteract the 
pro-inflammatory effects of M(IFNγ+TNFα) MCM, since NO levels were not reduced when M(IFNγ+TNFα) 
MCM was combined with M(IL-4) or M(IL-10) and expression levels of the majority of the genes of interest, 
were not rescued by M(IL-4) and M(IL-10) MCM.  This was somewhat unexpected since it was demonstrated 
earlier that monocytes stimulated with macrophage colony-stimulating factor (M-CSF), enhanced 
chondrogenesis in vitro [23]. This discrepancy could be explained by the fact that processes during 
chondrogenesis are different than processes occurring in mature, degenerating cartilage. Furthermore, the 
anti-inflammatory macrophages in our study were not polarized by M-CSF, but with IL-4 and IL-10. Even when 
extra inflammation was induced in OA cartilage, M(IL-10) MCM in our study did not have an effect on any of 
the genes of interest. M(IL-4) MCM on the other hand, reduced ACAN expression of the stimulated cartilage to 
some extent. When M1 and M2 MCM were combined, anti-inflammatory macrophages were also unable to 
inhibit the inflammatory effects of M(IFNγ+TNFα) MCM. In the current study, a concentration of 50% MCM 
was used. Although with this concentration M(IFNγ+TNFα) MCM affected OA cartilage, while M2 MCM did 
not have a clear effect, it cannot be ruled out that higher concentrations of M2 MCM would have affected 
cartilage. Our results suggest that the products of anti-inflammatory macrophages only may not be sufficient or 
potent enough for directly suppressing inflammation in cartilage in this system, but interaction between 
macrophages of different phenotypes may be required to initiate biological actions.  One should therefore realize 
that other in vitro or in vivo models may be needed to further investigate the mechanisms of the role of 
macrophage subtypes on either protecting cartilage or inducing degeneration and inflammation. A second 
limitation of our study is that the macrophage phenotypes were characterized based on three main factors, which 
were shown in our previous work [11] to be good markers for our generated phenotypes. More extensive 
characterization or profiling of soluble macrophage factors may help to pinpoint which active factor in 
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M(IFNγ+TNFα) MCM actually affected the cartilage. That knowledge may then be used to develop targeted 
therapies.  
 
This in vitro model enabled us to study the direct effect of factors secreted by macrophages of different 
phenotypes on cartilage inflammation and degeneration. The use of human cartilage explants and primary 
human macrophages makes translation of the results to the clinical situation more realistic. The variability of the 
cartilage between donors and within samples of the same donors is, however, an inevitable disadvantage of the 
use of human cells and tissues. Although macroscopically preserved cartilage was used in the experiments, 
differences in local degeneration of the used tissue resulted in variable baseline levels of GAG, varying 
chondrocyte viability and inflammatory state, as seen by the high variability within donors in our experiments. 
In this model, MCM had clear effects on production of NO. In the majority of our experiments, however, GAG 
release was unaffected by MCM. The release of GAG is influenced by multiple processes such as production 
and breakdown. Longer culture periods may be necessary to be able to observe effects on GAG release. Though 
an effect on GAG release was not detected, processes associated with cartilage degeneration were initiated by 
the macrophages, as indicated by decreased levels of ACAN and increased gene expression of cartilage 
degrading enzymes.  
 
Based on the data of this study, management of the behavior of synovial macrophages may seem a 
suitable approach to prevent cartilage degeneration. Additionally, the importance of the role of macrophages 
during wound healing and tissue regeneration in vivo models has been reported by others [24, 25]. Though we 
were unable to show a direct protective effect of anti-inflammatory macrophages on cartilage, we believe that 
this phenotype should not be completely disregarded, since an obvious interplay and balance between 
macrophage phenotypes and other cell types may contribute to their regenerative or protective capacity. More 
studies will be needed to fully understand this mechanism prior to clinical application. 
 
Conclusion 
 
M(IFNγ+TNFα) pro-inflammatory macrophages have a prominent direct effect on OA cartilage while 
M(IL-4) and M(IL-10) do not inhibit the inflammatory and degenerative effects of M(IFNγ+TNFα). This 
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knowledge may be taken into consideration when developing therapies aiming at inhibition of cartilage 
degeneration, by inhibiting pro-inflammatory macrophages or stimulating anti-inflammatory macrophages. 
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Table 1: Cartilage donor demographics and culture conditions 
Donor Gender Age 24h pre-stimulation 48h treatment No. of explants/condition 
1 Male 65 Non-stimulated 
DMEM 
M(IFNγ+TNFα) MCM 
M(IL-4) MCM 
M(IL-10) MCM 6 
2 Male 65 Non-stimulated 
DMEM 
M(IFNγ+TNFα) MCM 
M(IL-4) MCM 
M(IL-10) MCM 3 
3 Male 70 Non-stimulated 
DMEM 
M(IFNγ+TNFα) MCM 
M(IL-4) MCM 
M(IL-10) MCM 3 
4 Female 59 
Non-stimulated 
IFNγ+TNFα 
stimulation 
None (analyzed after 24h) 
DMEM 
M(IFNγ+TNFα) MCM 
M(IL-4) MCM 
M(IL-10) MCM 3 
5 Female 78 Non-stimulated 
DMEM  
M(IFNγ+TNFα) MCM  
M(IL-4) MCM  
M(IL-10) MCM 3 
6 Male 66 
Non-stimulated 
IFNγ+TNFα 
stimulation 
None (analyzed after 24h) 
DMEM 
M(IFNγ+TNFα) MCM 
M(IL-4) MCM  
M(IL-10) MCM 3 
7 Female 63 Non-stimulated 
DMEM 
M(IFNγ+TNFα) MCM 
M(IL-4) MCM 
M(IL-10) MCM 
M(IFNγ+TNFα)+M(IL-4) MCM 
M(IFNγ+TNFα)+M(IL-10) 
MCM 3 
8 Female 66 Non-stimulated 
DMEM 
M(IFNγ+TNFα) MCM 
M(IL-4) MCM 
M(IL-10) MCM 
M(IFNγ+TNFα)+M(IL-4) MCM 
M(IFNγ+TNFα)+M(IL-10) 
MCM 3 
9 Male 58 
Non-stimulated 
IFNγ+TNFα 
stimulation 
None (analyzed after 24h) 
DMEM 
M(IFNγ+TNFα) MCM 
M(IL-4) MCM 
M(IL-10) MCM 3 
10 Female 75 Non-stimulated 
DMEM 
M(IFNγ+TNFα) MCM 
M(IL-4) MCM 
M(IL-10) MCM 
M(IFNγ+TNFα)+M(IL-4) MCM 
M(IFNγ+TNFα)+M(IL-10) 
MCM 3 
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Figure 1: Protein concentrations in MCM. IL-6, CCL18 and sCD163 protein concentrations of 
M(IFNγ+TNFα), M(IL-4) and M(IL-4) MCM. Bars represent the mean of a duplicate measurement. U.D: 
undetectable. 
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Figure 2: OA cartilage is significantly affected by pro-inflammatory macrophages. (A) Expression of genes 
encoding for inflammatory proteins: IL1B, IL6, TNFA, SOCS1 and SOCS3, genes associated with matrix 
degeneration: MMP1, MMP13, ADAMTS4 and ADAMTS5, and genes associated with matrix components: 
ACAN and COL2A1 of OA cartilage cultured with MCM. The expression is shown relative to the expression of 
cartilage cultured with non-conditioned DMEM control medium represented by the dotted line. Data of all 
samples presented as dot plots including the grand median for n=6 cartilage donors with three samples per donor 
(six samples for donor 1). (B) NO production by cartilage after culture with MCM as an indication of the 
inflammatory state and GAG release as an indication of cartilage degeneration after culture with MCM. Data is 
presented relative to the NO production and GAG release of cartilage cultured in non-conditioned DMEM 
control medium represented by the dotted line for n=6 cartilage donors with three samples per donor (six 
samples for donor 1 and 2). Statistical evaluation was conducted with a linear mixed model after log 
transformation followed by a Bonferroni’s post hoc test. Abbreviations: IL1B: Interleukin-1β; IL6: 
Interleukin-6; TNFA: Tumor Necrosis Factor-α; SOCS1, -3: Suppressor of cytokine signaling 1, -3; MMP1, -13: 
matrix metalloproteinase-1, -13; ADAMTS4,-5: A disintegrin and metalloproteinase with thrombospondin 
motifs-4, -5; ACAN: aggrecan; COL2A1: collagen type II 
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Figure 3: M(IL-4) and M(IL-10) macrophages do not counteract the inflammatory effects of 
M(IFNγ+TNFα) on OA cartilage. (A) Gene expression levels, (B) NO production and (C) GAG release of OA 
cartilage after culture with single phenotype MCM or a combination of phenotypes. For the cultures with single 
phenotype MCM, the MCM was completed 1:1 with fresh DMEM to reach 50% MCM. For the cultures with 
combined phenotype MCM, 50% of each phenotype was used in the cultures. For the control medium, 
previously frozen non-conditioned DMEM was combined 1:1 with fresh DMEM. Data of all samples presented 
in dot plots including the grand median for n=3 cartilage donors with three samples per donor. Statistical 
evaluation was conducted with a linear mixed model after log transformation followed by a Bonferroni’s post 
hoc test. 
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Figure 4: Stimulation of OA cartilage with IFNγ+TNFα as a cartilage inflammatory model. To simulate 
acute inflammation, OA cartilage explants were pre-stimulated for 24h with IFNγ+TNFα. (A) The effect of 
IFNγ+TNFα pre-stimulation on gene expression levels, (B) NO production and release of GAG. Gene 
expression levels are shown relative to the expression of OA cartilage explants cultured in DMEM as 
represented by the dotted line. Data of all samples is presented in dot plots including the grand median for n=3 
cartilage donors with three samples for each donor. For statistical evaluation, a mixed linear model after log 
transformation was used followed by a Bonferroni’s post hoc test. 
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Figure 5: The effect of anti-inflammatory macrophages on acute inflamed cartilage. To assess potential 
effects of anti-inflammatory macrophages, acute inflamed cartilage (i.e. pre-stimulated with IFNγ+TNFα) was 
cultured with MCM. (A) Expression levels of IFNγ+TNFα pre-stimulated cartilage cultured with MCM. 
Expression is shown relative to the expression of pre-stimulated cartilage explants cultured in non-conditioned 
DMEM without IFNγ+TNFα as represented by the dotted line. (B) NO production and GAG release by 
IFNγ+TNFα pre-stimulated cartilage after culture with MCM relative to the controls cultured in DMEM as 
represented by the dotted line. Data of all samples is presented in dot plots including the grand median for n=3 
cartilage donors with three samples for each donor. For statistical evaluation, a mixed linear model after log 
transformation was used followed by a Bonferroni’s post hoc test.  
 
 
 
 
